Drug recall D-0184-2024
Product
HydrALAZINE Hydrochloride Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816. NDC: 23155-002-01
Reason for recall
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Lots and codes
Batch G210553, G210551
Recall details
- Recalling firm
- CARDINAL HEALTHCARE, Dublin, OH
- Quantity
- 2 units
- Distribution
- Nationwide USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- January 26, 2022
- Terminated
- September 29, 2024
Related products
- Hydralazine Hydrochloride – drug information
- NDC 23155-003 Hydralazine Hydrochloride · Hydralazine Hydrochloride 50 mg/1 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.